Quick-hitting policy analysis, polling, and updates on the key issues facing the country in 2020.
We recently estimated that the U.S. was close to its “COVID-19 vaccine tipping point” – that is, the point at which vaccine supply may start to outstrip demand. We also noted that national averages may mask important differences by state. We therefore sought to understand where states fall along this spectrum; such differences are important for understanding how best to target efforts to increase vaccine coverage throughout the country.
In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes towards government involvement in controlling health spending and whether it is part of a larger shift in comfort with government action to solve problems.Read Post
This summarizes the additional federal funding that has been given to health care providers to help them cope with the economic impact of the pandemic and also discusses the latest trends in health care spending.Read Post
For months, the main challenge with COVID-19 vaccine roll-out in the U.S. was that demand greatly outstripped supply. Indeed, limited supply, coupled with restricted eligibility in many parts of the country, meant that most people couldn’t get vaccinated if they wanted to. Now, with supply having increased significantly and eligibility fully open to adults in all states as of April 19, the main question has become, when will supply outstrip demand? While timing may differ by state, we estimate that across the U.S. as a whole we will likely reach a tipping point on vaccine enthusiasm in the next 2 to 4 weeks. Once this happens, efforts to encourage vaccination will become much harder, presenting a challenge to reaching the levels of herd immunity that are expected to be needed.
In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.Read Post
Dysfunctional websites are making it harder for Americans to get vaccinated. Here’s how to fix that.
In an op-ed for The Washington Post, Drew Altman spells out how COVID-19 vaccination can be simplified to ensure that the public’s rising confidence in the vaccine isn’t thwarted by frustrating and sometimes dysfunctional websites.Read Post